Literature DB >> 23882993

Ocular findings in patients with oculocutaneous albinism type ia with G47D tyrosinase gene mutation in Puerto Rico: a case report.

Ferdinand Rodríguez-Agramonte1, Natalio J Izquierdo, Carmen Cadilla.   

Abstract

UNLABELLED: Previous studies have suggested that the G47D mutation leads patients to develop Oculocutaneous albinism (OCA) type IA. This mutation has been described in the Canary Islands. Historically, there has been a migration from the Canary Islands to some regions of Puerto Rico.
OBJECTIVE: To report on the ocular findings of two Puerto Rican patients with OCA IA due to the G47D Tyrosinase gene mutation. PATIENT AND
FINDINGS: Two unrelated patients with OCA underwent a comprehensive eye examination and were referred for genetic analysis. Patients had almost total iris transillumination, clear lenses, foveal hypoplasia with transparent maculae, and albinotic mid peripheries. Both patients had nystagmus, and only one patient had strabismus.
CONCLUSIONS: Patients with the G47D muta- tion leading to OCA IA have poor visual acuities and poorly pigmented phenotypic ophthalmic findings. Further studies comparing ocular findings in patients th several mutations leading to OCA IA are warranted. To our knowledge this is the first report on ocular findings in Puerto Rican patients with OCA type IA with the rare G47D mutation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23882993      PMCID: PMC4042624     

Source DB:  PubMed          Journal:  Bol Asoc Med P R        ISSN: 0004-4849


  15 in total

1.  Molecular analysis of an extended family with type IA (tyrosinase-negative) oculocutaneous albinism.

Authors:  W S Oetting; H Y Handoko; M M Mentink; A S Paller; J G White; R A King
Journal:  J Invest Dermatol       Date:  1991-07       Impact factor: 8.551

2.  Organization and nucleotide sequences of the human tyrosinase gene and a truncated tyrosinase-related segment.

Authors:  L B Giebel; K M Strunk; R A Spritz
Journal:  Genomics       Date:  1991-03       Impact factor: 5.736

3.  Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Authors:  Pedro J Santiago Borrero; Yolanda Rodríguez-Pérez; Jessicca Y Renta; Natalio J Izquierdo; Laura Del Fierro; Daniel Muñoz; Norma López Molina; Sonia Ramírez; Glorivee Pagán-Mercado; Idith Ortíz; Enid Rivera-Caragol; Richard A Spritz; Carmen L Cadilla
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

4.  [An overview of oculocutaneous albinism: TYR gene mutations in five Colombian individuals].

Authors:  Diana Sanabria; Helena Groot; Julio Guzmán; María Claudia Lattig
Journal:  Biomedica       Date:  2012-06       Impact factor: 0.935

Review 5.  Albinism.

Authors:  R A King; C G Summers
Journal:  Dermatol Clin       Date:  1988-04       Impact factor: 3.478

6.  A frequent tyrosinase gene mutation associated with type I-A (tyrosinase-negative) oculocutaneous albinism in Puerto Rico.

Authors:  W S Oetting; C J Witkop; S A Brown; R Colomer; J P Fryer; K E Bloom; R A King
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

Review 7.  Albinism and the associated ocular defects.

Authors:  W S Oetting; C G Summers; R A King
Journal:  Metab Pediatr Syst Ophthalmol (1985)       Date:  1994

8.  Correlation of visual acuity with foveal hypoplasia grading by optical coherence tomography in albinism.

Authors:  Je Hyun Seo; Young Suk Yu; Jeong Hun Kim; Ho Kyung Choung; Jang Won Heo; Seong-Joon Kim
Journal:  Ophthalmology       Date:  2007-03-06       Impact factor: 12.079

Review 9.  Oculocutaneous albinism type 1A: a case report.

Authors:  Ali Karaman
Journal:  Dermatol Online J       Date:  2008-11-15

10.  Correction of abnormal retinal pathways found with albinism by introduction of a functional tyrosinase gene in transgenic mice.

Authors:  G Jeffery; G Schütz; L Montoliu
Journal:  Dev Biol       Date:  1994-12       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.